Chronic obstructive pulmonary disease and premature aging

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 12, 2007, Pages 1217-1218

  Vogelmeier, Claus ^a   Bals, Robert ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AIRFLOW; ATHEROSCLEROSIS; BONE DENSITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HUMAN; LUNG FUNCTION; MEDICAL LITERATURE; MORTALITY; OSTEOCLAST; OSTEOPOROSIS; PNEUMONIA; PRACTICE GUIDELINE; PREMATURE AGING; PRIORITY JOURNAL; PULSE WAVE; RIGIDITY;

AGING, PREMATURE; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34250160519     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200703-513ED     Document Type: Editorial

References (18)

1. Celli BR, MacNee W; Committee Members of the American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force. Standards for the diagnosis and treatment of COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive plumonary disease. Executive Summary; 2006. Available from: www.goldcopd.com (accessed December 2006).
3. Anthonisen NR, Connett JE, Kiley, JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-1505.
4. Sheifer SE, Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Breall JA, Schulman KA. Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation 2000;102:1651-1656.
5. Behar S, Panosh A, Reicher-Reiss H, Zion M, Schlesinger Z, Goldbourt U. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med 1992;93:637-641.
6. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockroft JR, Shale DJ. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:1259-1265.
7. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 2006;113:657-663.
8. Laurent S, Cockroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlahcopoulos C, Wilkinson I, Stuijker-Boudie H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605.
9. Eickhoff P, Kiss D, Kohansal R, Valipour A, Geyer K, Burghuber C. Endothelial dysfunction in stable COPD: a link between systemic inflammation and cardiovascular morbidity? Eur Respir J 2006;28:116s.
10. Bolton CE, Ionescu AA, Shiels KM, Petit RJ, Edwards PH, Stone MD, Nixon LS, Evans WD, Griffiths TL, Shale DJ. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-1293.
11. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 2004;89:4246-4253.
12. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag 2006;2:145-152.
13. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
14. Anandarajah AP, Schwarz EM. Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J Cell Biochem 2006;97:226-232.
15. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Orimo H. Influences of tobacco smoke inhalation on aging and oxidant-antioxidant balance in the senescence-accelerated mouse (SAM)-P/2. Exp Gerontol 1993;28:87-89.
16. Holz O, Zühlke E, Jaksztat E, Müller KC, Welker L, Nakashima M, Diemel KD, Branscheid D, Magnussen H, Jörres RA. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004;24:575-579.
17. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006;174:886-893.
18. Patel BD, Loo WJ, Tasker AD, Screaton NJ, Burrows NP, Silverman EK, Lomas DA. Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax 2006;61:568-571.